Equateq is at Informex 2009 showcasing its synthesised 98 per cent pure omega-6 DGLA, use of which has previously been restricted owing to difficulties obtaining it from natural sources.
Novavax believes its new $5m vaccine facility, which became operational this week, shows the cost and efficiency advantages of manufacturing with disposable, single use systems.
ALS Therapy Development Institute (ALS TDI) and Asklepios BioPharmaceutical have entered into a collaboration to develop viral vectors for drug delivery.
Health charity PATH has developed a formulation to stop vaccines suffering from freeze damage, which it believes will help ensure products are fully potent when they reach their destination.
Preterm infants are routinely exposed to pharmaceutical excipients at levels which could potentially be toxic, according to researchers at Leicester Royal Infirmary in the UK.
Ireland’s Merrion Pharmaceuticals’ GIPET oral delivery technology platform has won the firm its second licensing agreement with Danish insulin giant Novo Nordisk.
Teva has made a big push into the biosimilars market through a joint venture with Lonza, which will give the generics giant expertise in biologics manufacture.
In the latest part of its “beyond our borders” scheme, the US FDA is asking drugmakers to volunteer supply chain information for drugs and APIs sourced outside the USA.
BayBio has called on California’s leaders to enact legislation to promote biomanufacturing in response to the aggressive policies pursued by other states.
Wyeth Pharmaceuticals is continuing efforts to improve its capabilities in the formulation and delivery of RNA through a strategic partnership with Santaris Pharma.
Since its inauguration last year, IPEC China has been working to improve the quality of excipient manufacturing in the country. in-PharmaTechnologist spoke with organisation president Nevin Cheng about the steps the body has taken so far and what it will...
Abbott Laboratories has licensed Liquidia Technologies’ PRINT nanoparticle technology for the delivery of siRNA-based therapeutics, which have the potential to improve the company’s cancer portfolio.
Nitec has received approval in Europe for its rheumatoid arthritis treatment Lodotra making it the first product using SkyePharma’s propriety drug delivery technology Geoclock to come to market.
In the future it may be possible to grow supplies of blood platelets in bioreactors rather than relying on donated supplies, according to US researchers.
LyondellBasell, the world’s third largest petrochemicals firm and a major supplier to the drug industry, is close to bankruptcy according to widespread media reports as it struggles under the weight of a $26bn (€19.4) debt and a slump in demand for its...
US researchers have found a way to improve the yield of biopharmaceutical production by freeing up protein trapped in bacterial stores known as inclusion bodies.
US researchers have for the first time synthesised an important class of drug compounds - the aromatic polyketides - in Escherichia coli, a bacteria widely used in microbial production.
Pfizer has gained a license for the use of certain ZFP Nuclease (ZFNs) reagents from Sangamo BioSciences, which it will use to modify Chinese Hamster Ovary (CHO) cell lines.
Merck Serono has stumped up $13m (€9m) to add manufacturing rights to its Stimuvax licensing deal with Oncothyreon and buy up any remaining inventory of the candidate lung cancer vaccine.
Philips Home Healthcare Solutions has had a busy week, acquiring an Italian aerosol therapy business from Medel and a manufacturing facility in Guandong, China.
Australian drug development firm Cancer Therapeutics (CTx) has selected IDBS’ E-workbook and ActivityBase platforms to manage its global drug development programmes.
TransPharma Medical has received the European CE mark for its transdermal drug delivery device ViaDerm, which creates pores to allow a therapeutic through the skin.
Valeant continues its spending spree with the $285m acquisition of California-based research dermatology specialist Dow Pharmaceutical Sciences (DPS), in a further bid to cement its market position.
Although it is widely acknowledged that medical bracelets can be the difference between life and death, Australia’s Nanotechnology Victoria (NanoVic) has become the first to take the idea further with its insulin-delivering jewellery project.
One of Actavis’ Bulgarian production facilities is being bought out by the management, which will provide contract manufacturing services to the generic maker and other companies.
Final guidance on the cooperative manufacture of licensed biologics has been issued by the FDA, which gives companies an outline of how to share responsibilities through the production process.
Pantec Biosolutions has received CE marking for its painless laser epidermal system (P.L.E.A.S.E.), which it claims can facilitate transdermal delivery of high molecular weight drugs.
The latest research into the delivery of heparin was on display at this year’s AAPS, demonstrating the work that has been undertaken to improve administration methods.
News that US drugmaker Bristol-Myers Squibb (B-MS) is using its Foam Granulation Technology (FGT) to develop a second drug has worked formulation specialist Dow Wolff Cellulosics (DWC) into quite a lather.
Research into developing manufacturing methods to produce cheap antiretrovirals in Africa has been highlighted on World Aids Day by The Council for Scientific and Industrial Research (CSIR).
Following fresh criticism of the agency’s handling of the heparin case, in-PharmaTechnologist reports on a FDA official’s explanation of the what, the when and the why of the scandal, from first deaths to continued vigilance.
Questions about the safety in children of a number of azo dye food colourings which are routinely found in pharmaceutical products could be answered within the next 18 months, according to the European Food Safety Agency (EFSA).
Taiwanese API maker ScinoPharm has been granted a US patent for new crystalline forms of irinotecan which are designed to allow for easier filtration during production processing.
Irish oral dosage specialist Merrion Pharmaceuticals is to develop and commercialise Novo Nordisk’s range of insulin analogues as the Danish firm seeks to tighten its grip on the $9bn (€7bn) a year diabetes market.
MicroCHIPS scooped the drug delivery technology award at this year’s AAPS, after which CEO John Santini spoke to in-PharmaTechnologist.com about the device and what the future holds for the company.
The pharmaceutical industry’s vigilance in ensuring the safety of raw materials was criticised at this year’s AAPS, with significant, challenging alterations needed to improve the system.
Patheon has signed a slew of agreements to boost its portfolio of contract drug development and manufacturing services, forging new alliances with Omnicare, Depomed, Senopsys and Solvias.
Canada’s Orbus Pharma has decided to exit the contract manufacturing business, saying that the division “posed a distraction to the core business and generated low or negative margins.”
German chemical giant BASF chose this year’s AAPS meeting in Atlanta, US to showcase its growing library of USP excipient verification certificates, making good on its commitment to apply the highest manufacturing standards to this area of its business.
Manufacturers of ingredients used as excipients in pharmaceuticals have faced some regulatory problems with a series substances known as 'atypical actives'.
PharmaForm's new EPAS particle engineering technology, launched at this year's AAPS in Atlanta, US, may help drugmakers improve the solubility of insoluble actives without some of the costly and time consuming processing steps used by traditional...
New Zealand has approved clinical trials of Living Cell Technologies (LCT) type 1 diabetes treatment, which uses porcine cells encapsulated in a seaweed based gel.
